Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
147.50
-1.55 (-1.04%)
At close: Oct 1, 2026, 4:00 PM EDT
148.21
+0.71 (0.48%)
Pre-market: Oct 2, 2026, 6:10 AM EDT
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of $182.89 billion as of October 1, 2026. Its market cap has increased by 32.79% in one year.
Market Cap
182.89B
Enterprise Value
204.26B
1-Year Change
32.79%
Ranking
Category
Stock Price
$147.50
ChartMarket Cap Chart
Since December 1, 1998, Gilead Sciences's market cap has increased from $973.10M to $182.89B, an increase of 18,694.92%. That is a compound annual growth rate of 20.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 182.89B | 20.10% |
| Dec 31, 2025 | 152.28B | 32.28% |
| Dec 31, 2024 | 115.12B | 14.04% |
| Dec 29, 2023 | 100.94B | -6.25% |
| Dec 30, 2022 | 107.68B | 18.22% |
| Dec 31, 2021 | 91.08B | 24.72% |
| Dec 31, 2020 | 73.03B | -11.17% |
| Dec 31, 2019 | 82.21B | 1.60% |
| Dec 31, 2018 | 80.92B | -13.53% |
| Dec 29, 2017 | 93.58B | -0.81% |
| Dec 30, 2016 | 94.34B | -35.31% |
| Dec 31, 2015 | 145.83B | 2.55% |
| Dec 31, 2014 | 142.21B | 23.49% |
| Dec 31, 2013 | 115.15B | 106.93% |
| Dec 31, 2012 | 55.65B | 81.01% |
| Dec 30, 2011 | 30.74B | 4.49% |
| Dec 31, 2010 | 29.42B | -24.44% |
| Dec 31, 2009 | 38.94B | -16.37% |
| Dec 31, 2008 | 46.56B | 8.73% |
| Dec 31, 2007 | 42.82B | 43.43% |
| Dec 29, 2006 | 29.86B | 24.03% |
| Dec 30, 2005 | 24.07B | 58.92% |
| Dec 31, 2004 | 15.15B | 28.36% |
| Dec 31, 2003 | 11.80B | 76.49% |
| Dec 31, 2002 | 6.69B | 6.07% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Johnson & Johnson | 623.34B |
| AbbVie | 459.33B |
| Merck & Co. | 354.80B |
| Novartis AG | 270.16B |
| AstraZeneca | 246.55B |
| Amgen | 220.18B |
| Novo Nordisk | 166.45B |
| Pfizer | 160.27B |